Work

A phase I trial of LBH589 and bevacizumab for recurrent high-grade glioma (HGG).

Year: 2011

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2011.29.15_suppl.2050

Authors: J. Drappatz, J. J. Raizer, D. Schiff, A. S. Chi, T. Batchelor, S. M. Snodgrass, E. C. Quant, A. D. Norden, R. Beroukhim, S. A. Grimm, L. M. Doherty, A. S. Ciampa, D. C. LaFrankie, S. Ruland, M. Gerard, S. Hammond, P. Y. Wen

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2589182611

Cites:

Cited by: 7

Related to: 10